10
3/14/19 1 Direct-To-Consumer Testing: What You Need to Know Kate Principe, MS CGC Certified Genetic Counselor Regional Genetics Coordinator, Gulf Coast Texas Oncology I have no financial disclosures I will be discussing various laboratories and genetic testing products. Statement should not be considered an endorsement of a specific laboratory. I have not personally used any DTC products Learning Objectives Genetics 101 Credit: Myriad Genetics The Central Dogma 6

2019 Apr PA DTC Talk (1) - StarChapter · 2019-03-14 · •DTC companies only analyze SNPs that are VALIDATED •May analyze >600,000 SNPs in total, but report on only a fraction

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

3/14/19

1

Direct-To-Consumer Testing: What You Need to Know

Kate Principe, MS CGCCertified Genetic Counselor

Regional Genetics Coordinator, Gulf CoastTexas Oncology

I have no financial disclosures

I will be discussing various laboratories and genetic testing products. Statement should not be

considered an endorsement of a specific laboratory.

I have not personally used any DTC products

Learning Objectives

Genetics 101

Credit: Myriad Genetics

The Central Dogma

6

3/14/19

2

The Human Genome Types of Genetic Changes

Single Nucleotide Polymorphisms• “SNP”• Substitution of 1 base pair for another

• 2 or more versions of a sequence

• Used as markers for genetic disease / trait

•May not be causative!•May not impact protein function!

• COMMON!•Occurs in >1% of the general population•~10 million total SNPs in human genome

Pathogenic Variants • “Mutation”•DNA change that causes disease / increases risk

•Multiple types of mutations (large del/dup, single base pair change, etc• Affects protein function

• RARE!•Occurs in <1% of general population

1.1

1.5

2.0

10.0

0.1 1.0 10.0 30.0

Minor Allele Frequency (%)Log scale

Relative Risk (OR)

Log scaleTP53

PTEN

CDH1

STK11

BRCA1BRCA2

BRIP1PALB2

ATMCHEK2

TNCR9

6q*

MAP3K1

FGFR2

CASP8LSP1

2q

8q

FGFX

Rare to very rare, high-risk alleles

Rare, moderate-risk alleles

Common, individually lower-risk alleles

* 6q effects apparently limited to Ashkenazi Jewish populationChart from Foulkes, NEJM, November 18, 2008

Highly penetrant. If an allele is highly penetrant, then the trait it produces will almost always be apparent in an individual carrying the allele.

Low penetrance. An allele with low penetrance will only sometimes produce the symptom or trait with which it has been associated at a detectable level. In cases of low penetrance, it is difficult to distinguish environmental from genetic factors.

Credit: Mary Freivogel MS CGC

Type of Genetic Testing

Genotyping• Evaluates common mutations / variations associated / linked to a disease or trait

• Looks at SNPs ONLY

Sequencing• Full gene analysis for many different types of mutations• Typically done in combination w/other testing modalities (del/dup, etc)

•More thorough, but potential to uncover unknown significance results

Possible Results

Genotyping• SNP is present

• 1 copy• 2 copies

• SNP is absent

Sequencing• Positive• Negative• Variant of Uncertain Significance

Types of Genetic Testing

Direct to Consumer (DTC) Testing

• Initiated by consumer

• No MD / clinician involved

• Genotyping for SNPs

• Self pay• Ancestry, health

trait, entertainment-ome

Patient Initiated Testing

• Patient initiated• Doctor approved*• Full genetic

analysis• Self pay or

insurance• Cancer panels,

carrier screening, pharmacogenetics

Provider Initiated Testing

• Provider recommends and coordinates testing

• Diagnostic testing• Insurance (when

criteria are met)• Hereditary cancer

risk panels, cardiac, neurologic, etc

Credit: Andrea Forman MS CGC

* Doctor may be employed / contracted by lab

3/14/19

3

Types of Genetic Testing

• Ancestry(composition, haplogroups, DNA relatives)

• Traits (hair color, ear wax type)

• Paternity/relationship• Other (wine

preference)

• Carrier screening• Pharmacogenomics• Hereditary cancer• Adult onset disease

(Mendelian and multifactorial)

• Nutrigenomics (diet, supplementation)

• Sports/fitness (performance, injury)

• WGS/WES (healthy population)

• Skin (wrinkling, irritation, sun damage)

• Telomere length

Non-health related Health related

Credit: Mary Freivogel MS CGC

At Home genetic Tests

(health testing only)

DTC Patient initiated

There’s (apparently) a test for that!

Ancestry Testing

Ancestry Testing

•Methodology• Y chromosome testing•Mitochondrial DNA testing• SNP (preferred and more common method)

• Evaluate a large number of SNPs across a genome, compare results to reference panel to estimate someone’s ethnic background• Reference panel: people who have done testing previously, people with known ancestry, publicly available DNA databases

https://ghr.nlm.nih.gov/primer/dtcgenetictesting/ancestrytesting

Ancestry Testing

• Limitations• Human migration patterns• Reference panels differ from lab to lab

https://ghr.nlm.nih.gov/primer/dtcgenetictesting/ancestrytesting

3/14/19

4

Ancestry Testing

• Considerations• Cultural ancestry vs. genetic ancestry• Family secrets

Ancestry Testing in the News

Health Testing

23andMe

Can opt out of genetic risk report

www.23andme.com

23andMe: BRCA

www.23andme.comwww.23andme.com

3/14/19

5

23andMe: BRCA

• 1/40 individuals of Ashkenazi Jewish ancestry will have 1 of these 3 BRCA1/2 mutations

•>1800 BRCA1/2 variants and counting…

•What about other breast and ovarian cancer genes????

23andMe: Social Media

Credit: Andrea Forman MS CGC

23andMe: Future Testing

•Will assess 2 common genetic variants in MUTYH gene• c.536A>G, c.1187G>A

• 1-2% of general population carries 1 MUTYH mutation• Slight increase in colon cancer risk

• If you carry 2 MUTYH mutations: MUTYH-associated polyposis• 70-100% colon cancer risk

•What about other colon cancer genes????

www.23andme.com

REMEMBER: Most disease risk is multifactorial!

23andMe

www.23andme.com

23andMe

= ACOG www.23andme.com

3/14/19

6

23andMe

www.23andme.com

23andMe

What’s missing?• Spinal muscular atrophy• Alpha thalassemia• Fanconi anemia group A• Fanconi anemia group C• Joubert disease

www.23andme.com

Genopalate

• 104 SNPs related to how the body processes food•Metabolism• Absorption

• Results:• Recommended intake level of 26 nutrients•Gluten and lactose sensitivity• Caffeine and alcohol metabolic rate• “Your Foods”

• Comprehensive food list that have nutrients you will benefit from the most, based on your DNA

www.genopalate.com

Considerations…

www.23andme.com

Considerations…

80% agree to participate in research

www.23andme.com

Considerations…

3/14/19

7

Ethical Considerations

• No minimum ordering age…• Parents can order a 23andMe health trait kit for their children

The “Entertainment-ome”(phrase coined by Scott Weissmann, MS CGC)

23andMe

www.23andme.com

Raw Data

Raw Data

•DTC companies only analyze SNPs that are VALIDATED•May analyze >600,000 SNPs in total, but report on only a fraction

• Some DTC companies will give you the option to download your raw data • FOR RESEARCH, EDUCATIONAL, AND RECREATIONAL PURPOSES ONLY

3rd party interpretation tools

• Promethease• Runs raw data through SNPedia.com

• Enlis Genetics• Software to analyze SNP data

•Genetic Genie•Methylation and detox analysis

• XCode Life• “Tailored” diet and exercise plans, allergies, skin care recs

• Stratagene•MTHFR and “epigenetic analysis”

PSEUDOSCIENCE

Credit: Andrea Forman MS CGC

3/14/19

8

Raw Data

Credit: Erynn Gordon MS CGC

Raw Data

www.Promethease.com

Raw Data

www.promethease.com; Ancestry.com Sample1 test patient

Pitfalls of Raw Data

43 variants sent for testing

17/43: false positive

8/43: confirmed, but classified inaccurately (pathogenic by raw data, benign or VUS by clinical lab)

Pitfalls of Raw Data

Tandy-Connor et al., 2018

Pitfalls of Raw Data

3/14/19

9

My patient brought me their DTC results… NOW WHAT?!

Questions to ask

(1) Motivations•What motivated the patient to undergo at home genetic testing / assess their raw data?• Are there specific health conditions the patient is concerned about?• Before testing? After testing?

(2) Personal and Family History• Are there health conditions the patient may be at increased risk for, based on personal or family history?

(3) REFER to a genetics professional

Credit: Lisa Madlensky, PhD, CGC

Genetic Counseling for DTC

** Most in-person genetic counselors will not see a patient just for DTC results review **

If there is…• Raw data that needs clinical confirmation• Personal/family history that warrants additional work up

Send the patient to a local genetic counselor

Genetic Counseling for DTC

DTC is everywhere…

www.amazon.com, searched: “Genetic testing”

3/14/19

10

…even at your local Target

DNA is NOT destiny

Resources

QUESTIONS?

[email protected]